申请人:——
公开号:US20030114465A1
公开(公告)日:2003-06-19
Compounds of the formula I
1
or a pharmaceutically acceptable salt, solvate or N-oxide thereof, wherein
X is ═CH— or ═N—;
Y is H, halogen, trihaloalkyl, alkyl, alkenyl, cycloalkyl, cycloalkyl, SH, —S-alkyl, or —CN.
R is alkyl, —CF
3
, cycloalkyl, heterocycloalkyl, heterocycloalkyl-alkyl, heteroarylalky or adamantyl, or optionally substituted phenyl, phenoxyalkyl, phenylthioalkyl, pyridyl, thienyl, thiazolyl, pyrazinyl, 1,2,5,6-tetrahydropyridine or
2
wherein R
10
and R
11
are hydrogen, alkyl or together form a cycloalkyl, are disclosed, as well as pharmaceutical compositions and methods of using said compounds in the treatment of eating disorders and diabetes.
式 I 的化合物
1
或其药学上可接受的盐、溶液或 N-氧化物,其中
X是═CH-或═N-;
Y 是 H、卤素、三卤代烷基、烷基、烯基、环烷基、环烷基、SH、-S-烷基或-CN。
R 是烷基、-CF
3
、环烷基、杂环烷基、杂环烷基烷基、杂芳基烷基或金刚烷基,或任选取代的苯基、苯氧基烷基、苯硫基烷基、吡啶基、噻吩基、噻唑基、吡嗪基、1,2,5,6-四氢吡啶或
2
其中 R
10
和 R
11
是氢、烷基或共同形成环烷基,本研究公开了使用上述化合物治疗饮食失调症和糖尿病的药物组合物和方法。